Showing 1 - 20 results of 56 for search 'Cortellini, Alessio', query time: 0.31s Refine Results
The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a “transcriptomic compass”?
The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”

Family history of cancer and DNA damage response genes: Two sides of the same coin?
A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients

Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on Dialysis
Cancer Care After Natural Disaster: Different Countries, Similar Problems

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
“Vessels in the Storm”: Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer

Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer
Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy

Home Care for Cancer Patients During COVID-19 Pandemic: The Double Triage Protocol
Rare bone toxicity associated with vismodegib

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome

Where are we with treatment options after first line in small cell lung cancer?—report of two opposite cases treated with CAPTEM regimen and possible perspectives
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management

Single‐institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non‐small cell lung cancer patients treated with first‐line chemotherapy
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non‐small cell lung cancer patients: A “hypothesis‐generator” preliminary report

Multicentric retrospective analysis of platinum‐pemetrexed regimens as first‐line therapy in non‐squamous non‐small cell lung cancer patients: A “snapshot” from clinical practice
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

Search Tools: Get RSS Feed — Email this Search — Save Search